Scarica l'app Stockscreener
26.33
3.27%
-0.89
Dopo l'orario di chiusura:
26.33
Precedente Chiudi:
$27.22
Aprire:
$27.235
Volume 24 ore:
1.36M
Relative Volume:
1.02
Capitalizzazione di mercato:
$3.89B
Reddito:
$15.06M
Utile/perdita netta:
$-242.05M
Rapporto P/E:
-14.46
EPS:
-1.8204
Flusso di cassa netto:
$-181.28M
1 W Prestazione:
+1.46%
1M Prestazione:
+6.56%
6M Prestazione:
+20.72%
1 anno Prestazione:
+56.08%
Intervallo 1D:
$25.72
$27.45
Intervallo di 1 settimana:
$25.06
$28.80
Portata 52W:
$9.60
$30.58
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Nome
Centessa Pharmaceuticals Plc Adr
Settore
Industria
Telefono
44 7391 789784
Indirizzo
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
26.33 | 3.89B | 15.06M | -242.05M | -181.28M | -1.8204 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-24 | Iniziato | Wolfe Research | Outperform |
| 2025-12-10 | Ripresa | Oppenheimer | Outperform |
| 2025-10-28 | Iniziato | Stephens | Overweight |
| 2025-09-03 | Iniziato | Wells Fargo | Overweight |
| 2025-08-29 | Ripresa | Oppenheimer | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-05-28 | Iniziato | Needham | Buy |
| 2025-05-08 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-31 | Iniziato | Piper Sandler | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-09-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Iniziato | B. Riley Securities | Buy |
| 2024-07-18 | Iniziato | Oppenheimer | Outperform |
| 2023-11-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-10-26 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Iniziato | Evercore ISI | Outperform |
| 2023-06-12 | Iniziato | Guggenheim | Buy |
| 2023-03-17 | Iniziato | SVB Securities | Outperform |
| 2022-08-12 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-02-11 | Iniziato | Goldman | Neutral |
Mostra tutto
Centessa Pharmaceuticals Plc Adr Borsa (CNTA) Ultime notizie
Centessa Pharmaceuticals CEO Touts ORX750 as Best-in-Class as Registration Studies Nearing Start - Yahoo Finance
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Has $27.08 Million Stock Position in BJ’s Restaurants, Inc. $BJRI - Defense World
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference - Yahoo Finance
Blue Owl Capital Holdings LP Reduces Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Royce & Associates LP Acquires New Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
CNTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TD Asset Management Inc Trims Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - AOL.com
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline - The Motley Fool
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Aberdeen Group plc - Defense World
Norsk Hydro ASA (OTCMKTS:NHYDY) Cut to “Strong Sell” at Kepler Capital Markets - Defense World
Eagle Health Investments LP Makes New Investment in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) - Finviz
Caprock Group LLC Buys New Stake in iShares Bitcoin Trust ETF $IBIT - Defense World
Centessa Pharmaceuticals CEO Teases “Transformational” 2026 as ORX750 Nears Registrational Trials - Yahoo Finance
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownWhat's Next? - MarketBeat
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 1,010 Shares of Stock - MarketBeat
WCM Investment Management LLC Increases Stock Position in Novo Nordisk A/S $NVO - Defense World
Best Infrastructure Stocks To Watch Now – January 31st - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Federated Hermes Inc. Purchases Shares of 1,749,650 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Truist Hikes Centessa (CNTA) PT to $33 While Maintaining Consistent 2026 Thesis - Finviz
A Look At Centessa Pharmaceuticals (CNTA) Valuation After New Analyst Focus On Orexin Pipeline Expansion - Sahm
Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal - Finviz
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa appoints orexin program founder Accardi as new CEO - Investing.com
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - setenews.com
Stempoint Capital LP Increases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Accardi sells Centessa (CNTA) shares worth $288,288 - Investing.com
Centessa Pharma president sells shares for $300,000 By Investing.com - Investing.com South Africa
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results - Finviz
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 10,000 Shares of Stock - MarketBeat
Centessa Pharma president sells shares for $300,000 - Investing.com India
100,362 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Bollard Group LLC - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighStill a Buy? - MarketBeat
Affinity Asset Advisors LLC Sells 646,500 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals stock hits all-time high at 29.99 USD - Investing.com
Centessa Pharmaceuticals Plc Adr Azioni (CNTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):